The investigation of capillary-to-arteriole signaling during functional hyperemia and its potential impairment in pathological conditions will be observed.
Our study is seeking individuals aged 55-85, who have been diagnosed with Mild Cognitive Impairment (MCI) and are at risk for Alzheimer's Disease. The goal of the study is to see whether cannabidiol (CBD) can improve MCI symptoms.